Intraperitoneal photodynamic therapy causes a capillary-leak syndrome

Annals of Surgical Oncology

Volumn 10, Issue 5, 2003, Pages 514-524

  Canter, Robert J ^a   Mick, Rosemarie ^a   Kesmodel, Susan B ^a   Raz, Dan J ^a   Spitz, Francis R ^a   Metz, James M ^b   Glatstein, Eli J ^b   Hahn, Stephen M ^b   Fraker, Douglas L ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Capillary leak syndrome; Carcinomatosis; Photodynamic therapy; Sarcomatosis

Indexed keywords

PHOTOFRIN; PHOTOSENSITIZING AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANASTOMOSIS; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; BLOOD TRANSFUSION; CAPILLARY LEAK SYNDROME; CARCINOMATOUS PERITONITIS; CRYSTALLOID; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTUBATION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PATIENT MONITORING; PERIOPERATIVE PERIOD; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; INFUSION; MIDDLE AGED; PERITONEUM TUMOR; PHASE 2 CLINICAL TRIAL; PHOTOCHEMOTHERAPY; RETROSPECTIVE STUDY;

ADULT; CAPILLARY LEAK SYNDROME; FEMALE; HUMANS; INFUSIONS, PARENTERAL; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; PHOTOCHEMOTHERAPY; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0041784834     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2003.11.005     Document Type: Article

References (31)

1. Berek JS, Bertelsen K, du Bois A, et al. Advanced epithelial ovarian cancer: 1998 consensus statements. Ann Oncol 1999;10(Suppl 1):87-92.
2. Schellinx ME, von Meyenfeldt MF, Sugarbaker PH. Peritoneal carcinomatosis from adenocarcinoma of the colon. Cancer Treat Res 1996;81:247-60.
3. Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 1992;215:68-77.
4. Benson RC Jr. Laser photodynamic therapy for bladder cancer. Mayo Clin Proc 1986;61:859-64.
5. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905.
6. Oleinick NL, Evans HH. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 1998;150(5 Suppl):S146-56.
7. 14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 1979;39:146-51.
8. Peng Q, Soler AM, Warloe T, et al. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B 2001;62:140-5.
9. Hendren SK, Hahn SM, Spitz FR, et al. Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Ann Surg Oncol 2001;8:65-71.
10. DeLaney TF, Sindelar WF, Tochner Z, et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int J Radiat Oncol Biol Phys 1993;25:445-57.
11. Sindelar WF, DeLaney TF, Tochner Z, et al. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study. Arch Surg 1991;126:318-24.
12. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818-24.
13. Gurevich I. Surgical site infections: simplifying the definitions. Infect Control Hosp Epidemiol 1995;16:667-8.
14. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996;125:680-7.
15. Lemeshow S, Hosmer DW Jr. Estimating odds ratios with categorically scaled covariates in multiple logistic regression analysis. Am J Epidemiol 1984;119:147-51.
16. Vollset SE, Hirji KF, Afifi AA. Evaluation of exact and asymptotic interval estimators in logistic analysis of matched case-control studies. Biometrics 1991;47:1311-25.
17. Hirji KF, Elashoff RM, Moore DH II, Bennett DE. Exact versus asymptotic analysis for a matched case-control study. Stat Med 1988;7:765-72.
18. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Cure Med 1996;24:163-72.
19. Moore FA, Moore EE, Read RA. Postinjury multiple organ failure: role of extrathoracic injury and sepsis in adult respiratory distress syndrome. New Horiz 1993;1:538-49.
20. Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling - regulation of the immune response in normal and critically ill states. Crit Care Med 2000;28(4 Suppl):N3-12.
21. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000;181:176-80.
22. Pinsky MR, Vincent JL, Deviere J, et al. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993;103:565-75.
23. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999;27:1230-51.
24. Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL. Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J 2001;15:879-92.
25. Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000;191:38-46.
26. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997;226:248-57; discussion 257-60.
27. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 1999;230:392-400; discussion 400-3.
28. Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996;77:2622-9.
29. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6:790-6.
30. Alonso O, Sugarbaker PH. Adult respiratory distress syndrome occurring in two patients undergoing cytoreductive surgery plus perioperative intraperitoneal chemotherapy: case reports and a review of the literature. Am Surg 2000;66:1032-6.
31. Esquivel J. Angulo F, Bland RK, et al. Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open "coliseum technique". Ann Surg Oncol 2000;7:296-300.